Sep 12th, 2018
Last month, the first generic version of the life-saving EpiPen was approved by the U.S. Food and Drug Administration (FDA). This is celebratory news for those with anaphylactic reaction to insect bites, foods, medications, latex, etc., which occurs in one of 50 people in the United States. EpiPen consists of the drug epinephrine and an ...
The DOJ has been busy reclaiming billions of federal healthcare dollars. It’s impressive that the U.S. Department of Justice (DOJ) Office of Public Affairs can send out a press release with the headline Justice Department Recovers Over $3.7 Billion From False Claims Act Cases in Fiscal Year 2017. It shows that, last year, the government ...
Jun 1st, 2017
eClinicalWorks (ECW), located in Westborough, Mass., has agreed to pay $155 million to avoid prosecution for alleged False Claims Act violations. The U.S. Department of Justice (DOJ) accused ECW of misrepresenting the capabilities of its electronic health record (EHR) software and paying kickbacks to certain customers in exchange for promoting its product. The DOJ contends that ...
Part 1: Bolster the areas where your incident-to and shared billing falls short. There are several major issues facing compliance officers today, such as HIPAA, Stark Law, and Anti-kickback Statute issues, as well as many billing compliance issues. Billing issues continue to appear in federal government False Claims Act settlement agreements and government audit reports. ...
Sep 3rd, 2015
True or False: It is permissible for providers to offer their Medicare/Medicaid patients drug manufacturer coupons for brand name drugs. The answer is: False. Such inducements may cause beneficiaries to seek expensive, brand name drugs in lieu of cheaper generic drugs, which causes the government’s costs to increase without any medical benefit to the beneficiaries. ...